The centre brings together cutting-edge technology, globally recognised diagnostic protocols, and a team of highly trained technical professionals

Cipla has launched Cipla’s first Breathefree Lung Wellness Center in Lajpat Nagar in New Delhi. This will be India’s first-of-its-kind integrated lung diagnostics and wellness centre, set to redefine respiratory care by making world-class, advanced standardised lung diagnostics both accessible and affordable for doctors and patients across the country.

The centre brings together cutting-edge technology, globally recognised diagnostic protocols, and a team of highly trained technical professionals who perform tests with precision, enabling doctors to detect respiratory diseases early and accurately.

The centre will provide a comprehensive gamut of over 60 tests covering lung physiology, microbiology, immunology, blood chemistry and radiology. The aim is to enable a more comprehensive evaluation of the lungs for patients suspected of having a respiratory disease or those already diagnosed with a lung condition - ranging from common diseases like Asthma and COPD to more complex ones such as interstitial lung diseases (ILD). Tests include Spirometry, Oscillometry, FeNO, DLCO, Body Plethysmography, FnNO, CPET, X-Ray and CT scan, sleep studies, etc. which will be conducted by highly trained technicians to eliminate errors and inconsistencies. In addition, the center will also provide pulmonary nutrition and rehabilitation services, and counselling for smoking cessation to aid patients on their rehabilitation journeys. The center is now open and currently welcoming patients through referrals from clinicians, offering the highest standards in respiratory diagnostics and care.

Achin Gupta, Global Chief Operating Officer, Cipla, said, “Cipla has long been a pioneer in respiratory care, and with the launch of the first Breathefree Lung Wellness Center, we are addressing a critical gap in the diagnostic landscape. By expanding our presence across the care continuum, we are aiming to transform lung health diagnostics in India by making high-quality, standardised lung diagnostics accessible to healthcare professionals and patients, ultimately improving respiratory health outcomes.”

Dr Jaideep Gogtay, Global Chief Medical Officer, Cipla Limited, added, “India is estimated to have over 90 million people with chronic respiratory diseases. Early and accurate diagnosis is crucial for physicians to initiate appropriate treatment for their patients, reduce the risk for hospitalisation and improve the quality of life. Cipla has always recognised the need to address this burden, and the launch of this center is a natural extension of our lung leadership efforts. Through this initiative, we aim to transform lung health diagnostics in India by strengthening the foundation of respiratory care.”